Michigan Medicine receives grant recognizing it as a top U.S. program for spinal cord injury

The official funding for the Michigan Spinal Cord Injury Model System will start on Sept. 1, 2022.

Author | Noah Fromson

Joining fewer than 20 health systems in the United States, Michigan Medicine’s Department of Physical Medicine and Rehabilitation received a federal research grant for spinal cord injury – reflecting its comprehensive care for patients with SCI and signifying the program as a national leader in the field.

Michigan Medicine rejoins the Spinal Cord Injury Model System program, a network of health systems supported by the National Institute on Disability, Independent Living, and Rehabilitation Research, within the U.S. Department of Health and Human Services, to serve as center of excellence for SCI research and clinical care. The University of Michigan had previously been funded as SCIMS Center from 1985 until 2016.

This time, Michigan Medicine is partnering with Mary Free Bed Rehabilitation Hospital in Grand Rapids, Mich., to form the Michigan Spinal Cord Injury Model System with the vision of enhancing health care and quality of life for individuals living and aging with SCI throughout the state.

There are nearly 300,000 people living with spinal cord injuries in the country. As therapies advance that allow individuals with SCI to live longer, healthier lives, the range of treatments required for the population is extensive and encompasses acute and post-acute care.

“Most health care providers have neither the awareness nor the training to support individuals with spinal cord injury, and we plan to develop and integrate the tools and research to enhance health and facilitate proactive clinical decision making through the work of this SCI model system,” said Michelle Meade, Ph.D., principal investigator and director of MI-SCIMS, co-director of the U-M Center for Disability Health and Wellness and professor of physical medicine and rehabilitation at U-M Medical School.

The group’s site-specific research project will develop and test the reliability and predictive validity of an SCI Hospitalization Risk Index. The tool will use information extracted from claims data, as well as electronic health records, to predict hospitalization for adults with chronic SCI using machine learning. Researchers will also assess the relationships between executive functioning, self-management and psychosocial outcomes among adults with chronic SCI to inform future interventions.

“Ultimately, the goal is to maintain and improve the health, well-being and quality of life of individuals with SCI and encourage gratifying, fulfilling relationships and experiences in their homes and in their communities,” said Gianna Rodriguez, M.D., co-principal investigator of MI-SCIMS and an associate professor of physical medicine and rehabilitation at U-M Medical School.

Official funding for the Michigan Spinal Cord Injury Model System will start on Sept. 1, 2022, however both Michigan Medicine and Mary Free Bed Rehabilitation are already collaborating to conduct research activities and ensure excellence in clinical care for individuals with SCI.

About Michigan Medicine: At Michigan Medicine, we advance health to serve Michigan and the world. We pursue excellence every day in our five hospitals, 125 clinics and home care operations that handle more than 2.3 million outpatient visits a year, as well as educate the next generation of physicians, health professionals and scientists in our U-M Medical School.

Michigan Medicine includes the top ranked U-M Medical School and University of Michigan Health, which includes the C.S. Mott Children’s Hospital, Von Voigtlander Women’s Hospital, University Hospital, the Frankel Cardiovascular Center, Kellogg Eye Center, University of Michigan Health West and the Rogel Cancer Center. The U-M Medical School is one of the nation's biomedical research powerhouses, with total research funding of more than $500 million.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Cannabis and psychedelics: stigmatized substances or powerful therapeutics?
Today on The Fundamentals is Dr. Kevin Boehnke, research assistant professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. His current research focuses on therapeutic applications of cannabis and psychedelics. His goal is to rigorously assess appropriate use of these substances and to help address the public health harms caused by their criminalization.
Health Lab
Mother-son heart bond: Woman relives congenital heart journey through newborn
A mother relives congenital heart journey through newborn.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Treating Diabetes & Weight: The Ozempic & Wegovy Effect
Today on The Fundamentals, our guest Dr. Martin Myers, Director of the U-M Elizabeth Weiser Caswell Diabetes Institute, discusses diabetes research in the context of Ozempic, Wegovy, and other drugs that are changing how people think about weight loss. You can learn more about Dr. Myers here, and you can follow the department of molecular and integrative physiology @UMPhysiology on X.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
If they don't give up, how can I give up?
Today on The Fundamentals is Dr. Maria Castro, the R.C. Schneider collegiate professor of neurosurgery, and a professor of cell and developmental biology at the University of Michigan Medical School. Her research program aims to develop immunotherapies for primary and metastatic brain cancer, studying basic immune biology mechanisms leading to clinical implementation. She has been inducted into the American Association for the Advancement of Sciences, the Latin American Academy of Sciences, and the American Institute for Medical and Biological Engineering College of Fellows. She has won numerous awards for her contributions to basic science and cancer research and is a diversity ambassador for the Cancer Biology Graduate Training Program. You can learn more about Dr. Castro here, and you can follow her @castro2355_mg, the Rogel Cancer Center @UMRogelCancer, the department of neurosurgery @umichneuro, Michigan Neurscience Institute @UM_MNI and the department of cell and developmental biology @UMCDB on X
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Addiction is a lifelong disease and not a moral failing
On today’s The Fundamentals is Dr. Brummett, Professor at the University of Michigan where he serves as the Senior Associate Chair for Research in the Department of Anesthesiology. He has more than 280 publications, including articles in top journals such as JAMA, JAMA Surgery, Anesthesiology, and Annals of Surgery. He is the Co-Director of the Opioid Prescribing Engagement Network or OPEN at the University of Michigan, which aims to apply a preventative approach to the opioid epidemic in the US through appropriate prescribing after surgery, dentistry and emergency medicine. Moreover, he is the Co-Director of the cross-campus Opioid Research Institute, which was launched in the spring of 2023. He leads multiple NIH grants studying these concepts and receives funding from the Michigan Department of Health and Human Services, SAMHSA, CDC, and multiple foundations. You can learn more about Dr. Brummett here, and you can follow Dr. Brummett @drchadb and the department of anesthesiology @UMichAnesthesia on X.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
From Patients to Progress: Advancing Autoimmune Research
Today on The Fundamentals, our guest is Dr. Michelle Kahlenberg, an Associate Professor of Internal Medicine and Dermatology, the Giles Bole and Dorothy Mulkey Research Professor of Rheumatology and the Vice Chair for Basic and Translational Research in Internal Medicine. Her clinical work is centered on the care of patients with lupus, including those with refractory skin disease. In addition to running her lab, she's an active member of the Immunology Training Program and has received national recognition for her research.